Contribution of specific amino acid changes in penicillin binding protein 1 to amoxicillin resistance in clinical Helicobacter pylori isolates

Antimicrobial Agents and Chemotherapy

Volumn 55, Issue 1, 2011, Pages 101-109

  Qureshi, Nadia N ^a   Morikis, Dimitrios ^b   Schiller, Neal L ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b University of California Riverside   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID; AMOXICILLIN; AMPICILLIN; CEFOTAXIME; PENICILLIN BINDING PROTEIN; PENICILLIN BINDING PROTEIN 1; PENICILLIN G; UNCLASSIFIED DRUG;

AMINO ACID SUBSTITUTION; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BINDING AFFINITY; HELICOBACTER PYLORI; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; SITE DIRECTED MUTAGENESIS;

AMINO ACID SEQUENCE; AMOXICILLIN; DRUG RESISTANCE, BACTERIAL; HELICOBACTER PYLORI; MOLECULAR SEQUENCE DATA; MUTAGENESIS, SITE-DIRECTED; PENICILLIN-BINDING PROTEINS; PROTEIN STRUCTURE, SECONDARY; SEQUENCE HOMOLOGY, AMINO ACID;

EID: 78650638191     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.00545-10     Document Type: Article

References (39)

1. Baker, N. A., D. Sept, S. Joseph, M. J. Holst, and J. A. McCammon. 2001. Electrostatics of nanosystems: application to microtubules and the ribosome. Proc. Natl. Acad. Sci. U. S. A. 98:10037-10041.
2. Bush, K. 2001. New beta-lactamases in gram-negative bacteria: diversity and impact on the selection of antimicrobial therapy. Clin. Infect. Dis. 32:1085-1089.
3. Cheung, A., C. Kieslich, J. Yang, and D. Morikis. 2010. Solvation effects in calculated electrostatic association free energies for the C3d-CR2 complex and comparison with experimental data. Biopolymers 93:509-519.
4. Co, E.-M. A., and N. L. Schiller. 2006. Resistance mechanisms in an in vitro-selected amoxicillin-resistant strain of Helicobacter pylori. Antimicrob. Agents Chemother. 50:4174-4176.
5. Contreras-Martel, C., V. Job, A. M. Di Guilmi, T. Vernet, O. Dideberg, and A. Dessen. 2006. Crystal structure of penicillin-binding protein 1a (PBP1a) reveals a mutational hotspot implicated in beta-lactam resistance in Streptococcus pneumoniae. J. Mol. Biol. 355:684-696.
6. Contreras-Martel, C., C. Dahout-Gonzalez, A. Dos Santos Martins, M. Kotnik, and A. Dessen. 2009. PBP active site flexibility as the key mechanism for β-lactam resistance in pneumococci. J. Mol. Biol. 387:899-909.
7. Dargis, M., and F. Malouin. 1994. Use of biotinylated beta-lactams and chemiluminescence for study and purification of penicillin-binding proteins in bacteria. Antimicrob. Agents Chemother. 38:973-980.
8. DeLoney, C. R., and N. L. Schiller. 1999. Competition of various beta-lactam antibiotics for the major penicillin-binding proteins of Helicobacter pylori: antibacterial activity and effects on bacterial morphology. Antimicrob. Agents Chemother. 43:2702-2709.
9. DeLoney, C. R., and N. L. Schiller. 2000. Characterization of an in vitroselected amoxicillin-resistant strain of Helicobacter pylori. Antimicrob. Agents Chemother. 44:3368-3373.
10. Dunn, B. E., H. Cohen, and M. J. Blaser. 1997. Helicobacter pylori. Clin. Microbiol. Rev. 10:720-741.
11. Frenck, R. W., Jr., and J. Clemens. 2003. Helicobacter pylori in the developing world. Microbes Infect. 5:705-713.
12. Gerrits, M. M., A. P. O. Godoy, E. J. Kuipers, M. L. Ribeiro, J. Stoof, S. Mendonca, A. H. M. van Vliet, J. Pedrazzoli, Jr., and J. G. Kusters. 2006. Multiple mutations in or adjacent to the conserved penicillin-binding protein motifs of the penicillin-binding protein 1A confer amoxicillin resistance to Helicobacter pylori. Helicobacter 11:181-187.
13. Gerrits, M. M., D. Schuijffel, A. A. Van Zwet, E. J. Kuipers, C. M. J. E. Vandenbroucke-Grauls, and J. G. Kusters. 2002. Alterations in penicillinbinding protein 1A confer resistance to β-lactam antibiotics in Helicobacter pylori. Antimicrob. Agents Chemother. 46:2229-2233.
14. Gerrits, M. M., A. H. M. van Vliet, E. J. Kuipers, and J. G. Kusters. 2006. Helicobacter pylori and antimicrobial resistance: molecular mechanisms and clinical implications. Lancet Infect. Dis. 6:699-709.
15. Guex, N., and M. C. Peitsch. 1997. SWISS-MODEL and the Swiss-Pdb-Viewer: an environment for comparative protein modeling. Electrophoresis 18:2714-2723.
16. Harris, A. G., S. L. Hazell, and A. G. Netting. 2000. Use of digoxigeninlabelled ampicillin in the identification of penicillin-binding proteins in Helicobacter pylori. J. Antimicrob. Chemother. 45:591-598.
17. Hu, C.-T., C.-C. Wu, C.-Y. Lin, C.-C. Cheng, S.-C. Su, Y.-H. Tseng, and N.-T. Lin. 2007. Resistance rate to antibiotics of Helicobacter pylori isolates in eastern Taiwan. J. Gastroenterol. Hepatol. 22:720-723.
18. Humphrey, W., A. Dalke, and K. Schulten. 1996. VMD: Visual Molecular Dynamics. J. Mol. Graphics 14:33-38.
19. Kwon, D. H., M. P. Dore, J. J. Kim, M. Kato, M. Lee, J. Y. Wu, and D. Y. Graham. 2003. High-level β-lactam resistance associated with acquired multidrug resistance in Helicobacter pylori. Antimicrob. Agents Chemother. 47: 2169-2178.
20. Malaguarnera, M., R. Bella, G. Algona, R. Ferri, A. Carnemolla, and G. Pennisi. 2004. Helicobacter pylori and Alzheimer's disease: a possible link. Eur. J. Intern. Med. 15:381-386.
21. Matteo, M. J., G. Granados, M. Olmos, A. Wonaga, and M. Catalano. 2008. Helicobacter pylori amoxicillin heteroresistance due to point mutations in PBP-1A in isogenic isolates. J. Antimicrob. Chemother. 61:474-477.
22. Megraud, F. 2004. H. pylori antibiotic resistance: prevalence, importance, and advances in testing. Gut 53:1374-1384.
23. Megraud, F., and P. Lehours. 2007. Helicobacter pylori detection and antimicrobial susceptibility testing. Clin. Microbiol. Rev. 20:280-322.
24. Mittl, P. R. E., L. Luthy, P. Hunzinger, and M. G. Grutter. 2000. The cysteine-rich protein A from Helicobacter pylori is a β-lactamase. J. Biol. Chem. 275:17693-17699.
25. Nedenskov-Sorensen, P., G. Bukholm, and K. Bovre. 1990. Natural competence for genetic transformation of Campylobacter pylori. J. Infect. Dis. 161:365-366.
26. Okamoto, T., H. Yoshiyama, T. Nakazawa, I.-D. Park, M.-W. Chang, H. Yanai, K. Okita, and M. Shirai. 2002. A change in PBP1 is involved in amoxicillin resistance of clinical isolates of Helicobacter pylori. J. Antimicrob. Chemother. 50:849-856.
27. Parkin, D. M. 2006. The global health burden of infection-associated cancers in the year 2002. Int. J. Cancer 118:3030-3044.
28. Paul, R., S. Postius, K. Melchers, and K. P. Schafer. 2001. Mutations of the Helicobacter pylori genes rdxA and pbp1 cause resistance against metronidazole and amoxicillin. Antimicrob. Agents Chemother. 45:962-965.
29. Rimbara, E., N. Noguchi, T. Kawai, and M. Sasatsu. 2007. Correlation between substitutions in penicillin-binding protein 1 and amoxicillin resistance in Helicobacter pylori. Microbiol. Immunol. 51:939-944.
30. Rimbara, E., N. Noguchi, T. Kawai, and M. Sasatsu. 2008. Mutations in penicillin-binding proteins 1, 2 and 3 are responsible for amoxicillin resistance in Helicobacter pylori. J. Antimicrob. Chemother. 61:995-998.
31. Rosenstock, S., T. Jorgensen, O. Bonnevie, and L. Andersen. 2003. Risk factors for peptic ulcer disease: a population based prospective cohort study comprising 2416 Danish adults. Gut 52:186-193.
32. Rothenbacher, D., and H. Brenner. 2003. Burden of Helicobacter pylori and H. pylori-related disease in the developed countries: recent developments and future implications. Microbes Infect. 5:693-704.
33. Sitkoff, D., K. A. Sharp, and B. Honig. 1994. Accurate calculation of hydration free energies using macroscopic solvent models. J. Phys. Chem. 98:1978-1988.
34. Tseng, Y.-S., D.-C. Wu, C.-Y. Chang, C.-H. Kuo, Y.-C. Yang, C.-M. Jan, Y.-C. Su, F.-C. Kuo, and L.-L. Chang. 2009. Amoxicillin resistance with β-lactamase production in Helicobacter pylori. Eur. J. Clin. Invest. 39:807-812.
35. Tsuda, M., M. Karita, and T. Nakazawa. 1993. Genetic transformation inHelicobacter pylori. Microbiol. Immunol. 37:85-89.
36. Wang, Y., K. P. Roos, and D. E. Taylor. 1993. Transformation of Helicobacter pylori by chromosomal metronidazole resistance and by a plasmid with a selectable chloramphenicol resistance marker. J. Gen. Microbiol. 139:2485-2493.
37. Wu, J., and D. Morikis. 2006. Molecular thermodynamics for charged biomacromolecules. Fluid Phase Equilibria 241:317-333.
38. Zhang, L., and D. Morikis. 2006. Immunophysical properties and prediction of activities for vaccinia virus complement control protein and smallpox inhibitor of complement enzymes using molecular dynamics and electrostatics. Biophys. J. 90:3106-3119.
39. Zhang, L., B. Mallik, and D. Morikis. 2007. Immunophysical exploration of C3d-CR2(CCP1-2) association using molecular dynamics and electrostatics. J. Mol. Biol. 369:567-583.